Development Level

Tbio 4 | 10,625
Tchem 1 | 1,890

IMPC Term

abnormal bone structure 1 | 131
abnormal cornea morphology 1 | 24
abnormal cranium morphology 1 | 32
abnormal lumbar vertebrae morp... 1 | 6
abnormal retina morphology 1 | 100
abnormal retinal pigmentation 1 | 61
abnormal snout morphology 1 | 18
corneal opacity 1 | 25
decreased Ly6C high monocyte n... 1 | 18
decreased T-helper cell number 1 | 4
decreased body length 1 | 108
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased effector memory CD8-... 1 | 24
decreased eosinophil cell numb... 1 | 41
decreased lean body mass 1 | 195
decreased monocyte cell number 1 | 28
decreased total body fat amoun... 1 | 186
improved glucose tolerance 1 | 56
increased CD4-positive, CD25-p... 1 | 18
increased CD4-positive, alpha ... 1 | 15
increased KLRG1+ CD4 alpha bet... 1 | 5
increased NK cell number 1 | 19
increased T cell number 1 | 15
increased alpha-beta T cell nu... 1 | 9
increased circulating alkaline... 1 | 119
increased circulating iron lev... 1 | 25
increased circulating total pr... 1 | 20
increased effector memory CD4-... 1 | 15
increased gamma-delta T cell n... 1 | 16
increased lean body mass 1 | 107
increased mean corpuscular hem... 1 | 93
increased mean corpuscular vol... 1 | 91
increased mean platelet volume 1 | 19
increased red blood cell distr... 1 | 21
increased rib number 1 | 41
male infertility 1 | 62
preweaning lethality, complete... 1 | 633
short snout 1 | 4
tremors 1 | 34
vertebral transformation 1 | 12

Disease

glioblastoma 5 | 5,572
osteosarcoma 5 | 7,933
medulloblastoma, large-cell 4 | 6,234
ovarian cancer 4 | 8,484
psoriasis 4 | 6,685
Cancer 3 | 2,346
Chromosome Breakage 3 | 5
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung cancer 3 | 4,466
primitive neuroectodermal tumor 3 | 3,031
Anemia 2 | 252
Ataxia telangiectasia 2 | 31
Breast cancer 2 | 3,094
Mammary Neoplasms 2 | 410
Neoplastic Cell Transformation 2 | 81
Nijmegen breakage syndrome 2 | 23
Pancreatic Neoplasm 2 | 79
Prostatic Neoplasms 2 | 471
astrocytic glioma 2 | 2,241
atypical teratoid / rhabdoid tumor 2 | 4,369
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
group 3 medulloblastoma 2 | 2,254
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
malignant mesothelioma 2 | 3,162
nasopharyngeal carcinoma 2 | 1,056
non-small cell lung cancer 2 | 2,798
ovarian neoplasm 2 | 97
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
Acquired immunodeficiency syndrome 1 | 164
Adenoid Cystic Carcinoma 1 | 99
Adenoma 1 | 165
Animal Mammary Neoplasms 1 | 136
Atopic dermatitis 1 | 944
Bladder Neoplasm 1 | 109
Breast Cancer, Familial 1 | 12
Breast disease 1 | 8
Burkitt Lymphoma 1 | 19
Chronic Lymphocytic Leukemia 1 | 242
Cleft Lip 1 | 91
Cleft palate 1 | 125
Colonic Neoplasms 1 | 126
Common variable immunodeficiency 1 | 72
Disease Progression 1 | 125
Endometriosis 1 | 535
Familial adenomatous polyposis 1 | 31
Fanconi's anemia 1 | 50
Fatty Liver 1 | 48
Hemangiosarcoma 1 | 18
Hemolytic anemia 1 | 66
Hypertrophic Cardiomyopathy 1 | 56
Left Ventricular Hypertrophy 1 | 24
Leukemia, Myelocytic, Acute 1 | 113
Li-Fraumeni Syndrome 1 | 13
Liver Neoplasms, Experimental 1 | 48
Liver carcinoma 1 | 217
Liver neoplasms 1 | 109
Lobular neoplasia 1 | 15
Lung Neoplasms 1 | 171
Lynch syndrome 1 | 33
MYELODYSPLASTIC SYNDROME 1 | 36
Malignant neoplasm of breast 1 | 63
Malignant neoplasm of ovary 1 | 13
Mammary Neoplasms, Experimental 1 | 150
Mouth Diseases 1 | 12
Multiple Sclerosis 1 | 498
Neoplasm Metastasis 1 | 138
Neoplasm Recurrence, Local 1 | 23
Neoplastic Syndromes, Hereditary 1 | 48
Neuroblastoma 1 | 78
Pancreatic carcinoma, familial 1 | 8
Peripheral Neuropathy 1 | 303
Peripheral vascular disease 1 | 90
Pick disease 1 | 1,893
Polycystic kidney disease 1 | 54
Prostate cancer 1 | 172
Seckel syndrome 1 | 34
Sickle cell anemia 1 | 35
Stomach Neoplasms 1 | 282
Thalassemia 1 | 46
Urinary bladder cancer 1 | 31
Werner syndrome 1 | 29
acute myeloid leukemia 1 | 780
acute quadriplegic myopathy 1 | 1,157
adrenocortical carcinoma 1 | 1,427
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
breast carcinoma 1 | 1,614
chronic rhinosinusitis 1 | 512
colon cancer 1 | 1,475
inflammatory breast cancer 1 | 404
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
medulloblastoma 1 | 1,524
non diabetic and post-ischemic heart failure 1 | 200
non-small cell lung carcinoma 1 | 413

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 4 | 11,971
Transcription Factor 1 | 1,400

Grant Application

1K22CA188106-01 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Myc proto-oncogene protein MYC Tbio Transcription Factor -4.07639 11730.8 2241
HBS1-like protein HBS1L Tbio Non-IDG -2.49189 316.2 144
Breast cancer type 1 susceptibility protein BRCA1 Tchem Non-IDG -3.72596 5756.8 1322
Structural maintenance of chromosomes protein 5 SMC5 Tbio Non-IDG -1.84413 79.4 93
Histone H2AX H2AFX Tbio Non-IDG -3.19144 1458.2 841